Prospective Clinical Trial of Preoperative Sunitinib in Patients With Renal Cell Carcinoma
To access this article, please choose from the options below
Supplementary material for this article can be obtained at http://www.csmc.edu/rcc.
Study received institutional review board approval.
Supported by Pfizer (HLK) and National Institutes of Health R01CA133072-01.
For another article on a related topic see page 1166.
PII: S0022-5347(10)03560-3
doi:10.1016/j.juro.2010.05.041
© 2010 American Urological Association Education and Research, Inc. Published by Elsevier Inc All rights reserved.

